期刊文献+

Ⅰa2-Ⅰb1期仅有低分化高危因素宫颈鳞癌患者术后治疗模式的探讨 被引量:3

Postoperative treatment mode of cervical squamous cell carcinoma patients in Ⅰa2-Ⅰb1 phase with only poorly differentiated high factors
原文传递
导出
摘要 目的:探讨Ia2-Ibl期仅有低分化高危因素宫颈鳞癌患者的治疗模式。方法:采用前瞻性随机对照研究的分析方法,将该院2007年1月-2012年12月收治的Ia2-Ibl期仅有低分化高危因素的宫颈鳞癌患者60例,分为单纯手术组(对照组)和手术+术后化疗组(观察组),总结所有患者手术并发症和观察组患者的化疗毒副反应。同时对两组间的复发率、3年累积无瘤生存率进行比较。结果:所有患者手术并发症的总发生率为33.33%(20/60),观察绀主要的毒副反应发生率为骨髓抑制16.67%(5/30),胃肠道反应23.33%(7/30),肝肾功能损害3.33%(1/30);对照组和观察组的复发率分别为6.67%和0.00%,差异无统计学意义(P〉0.05);3年累积无瘤生存分别为91.83%和100.oo%,差异无统计学意义(P〉0.05)。结论:手术+术后化疗对于仅有低分化高危因素的Ia2-Ib1期宫颈鳞癌患者是一种可行的治疗选择,患者可耐受手术联合单纯化疗的并发症和毒副反应,并获得较好的近远期疗效。 Objective: To explore the treatment mode of cervical squamous cell carcinoma patients in I a2 - I bl phase with only poorly differentiated high factors. Methods: A Prospective randomized case -control study was performed, 60 cervical squamous cell carci- noma patients in I a2 - I bl phase with only poorly differentiated high factors were selected from the hospital from January 2007 to Decem- ber 2012 were selected and divided into simple surgery group (control group) and surgery + postoperative chemotherapy group (observation group) ; the surgical complications in the two groups and adverse reactions of chemotherapy in observation group were summarized ; the recur- rence rates and three - year cumulative disease - free survival rates in the two groups were compared. Results : The overall incidence rate of postoperative complications was 33.3% (20/60), in observation group, the main adverse reactions were myelosuppression (16. 67%, 5/ 30) , gastrointestinal reaction (23.33 % , 7/30) , liver and renal dysfunction (3.33 % , 1/30) ; the recurrence rates in control group and ob- servation group were 6. 67% and 0. 00% , respectively, there was no statistically significant difference ( P 〉 0. 05 ) ; the three - year cumula- tive disease - free survival rates in control group and observation group were 91.83% and 100. 00% , respectively, there was no statistically significant difference (P 〉 0. 05 ) . Conclusion : Surgery combined with postoperative chemotherapy is a feasible treatment choice for cervi- cal squamous cell carcinoma patients in I a2 - I bl phase with only poorly differentiated high factors, the patients can tolerate the complica- tions and adverse reactions of surgery combined with simple chemotherapy, the short - term and long - term curative effects are good.
出处 《中国妇幼保健》 CAS 北大核心 2014年第7期1009-1011,共3页 Maternal and Child Health Care of China
基金 广西壮族自治区柳州市应用技术研究及技术开发课题〔2010030720〕
关键词 宫颈鳞癌 低分化 术后 化疗 Cervical squamous cell carcinoma Poor differentiation Postoperation Chemotherapy
  • 相关文献

参考文献7

  • 1Peters WA 3rd, Liu PY, Barrett RJ 2nd, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pel- vic radiation therapy alone as adjuvant therapy after radical surgery in high risk early stage cancer of the cervix J 3 . J Clin Oncol, 2000, 18 (8) : 1606.
  • 2Monk B J, Wang J, Im S, et al. Rethinking the use of radia- tion and chemotherapy after radical hysterectomy: a clinical pathologic analysis of a Gynecologic Oncology Group /South- west Oneology Group/Radiation Therapy Ontology Group trial (Jl Gynecol Oncol, 2005, 96 (3) : 721-728.
  • 3Grigsby PW. Cervical cancer: combined modality therapy IJ3 .Cancer J, 2001, 7 (1) : 47.
  • 4Takeshima N, Umayahara K, Fujiwara K, et al. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high -risk stage I B I1 A cervical canc- er J . Gynecol Oncol, 2006, 103 (2) : 618-622.
  • 5李萌,熊光武.宫颈癌的化疗[J].肿瘤预防与治疗,2008,21(4):353-357. 被引量:7
  • 6Lahousen M, Haas J, Pickel H, et al. Chemotherapy versus ra- diotherapy versus observation for high - risk cervical carcinoma after radical hysterectomy : a randomized, prospective, multi - center trial (J . Gynecol Oncol, 1999, 73 (2) : 196-201.
  • 7马珂,刘桐宇,黄伟萍,温宏武,廖秦平.手术及术后化疗治疗有复发中危和高危因素的ⅠB~ⅡA期宫颈癌68例疗效分析[J].实用妇产科杂志,2012,28(11):923-927. 被引量:18

二级参考文献46

  • 1苗华芹,周登光,周登峰.高危宫颈癌化疗进展[J].实用癌症杂志,2005,20(3):332-334. 被引量:2
  • 2宋红梅,吴福道,邓国忠,伍显庭.复发或转移宫颈癌的化疗疗效观察[J].四川肿瘤防治,2006,19(4):256-257. 被引量:2
  • 3余健,张国楠,樊英.同步放化疗治疗中晚期宫颈癌50例临床疗效观察[J].实用妇产科杂志,2007,23(5):287-289. 被引量:74
  • 4[3]Necadjuvant chemotherapy for locally advanced cervical cancer:a systematic review and recta-analysis of individual patient data from 21 randomized trials[J].Eur J Cancer,2003,39 (17):2470-2486.
  • 5[4]Hwang YY,Moon H,Cho SH,et al.Ten-year survival of patients with locally advanced,stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy[J].Gynecol Oncol,2001,82(1):88-93.
  • 6[5]Sardi JE,Giaroli A,Sanancs C,et al.Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix:the final resuhs[J].Gynecol Oncol,1997,67(1):61-69.
  • 7[6]Minagawa Y,Kigawa J,Irie T,et al.Radical surgery following necadjuvant chemotherapy for patients with stage ⅢB cervical cancer[J].Annals of Surgical Onoology,1998,5(6):539-543.
  • 8[7]Banadetti-Panici P,Greggi S,Colombo A,et al.Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced cervical cancer:results from the Italian multicenter randomised study[J].J Clin Oncol,2002,20:179-188.
  • 9[8]Eddy G,Bundy B,Creasman W,et al.Treatment of " bulky" stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy:a phase Ⅲ trial of the gynecologic oncology group[J].Gynecol Oncol,2007,106:362-369.
  • 10[9]Benedetti Panici P,Bellati F,Pastore M,et al.An update in neoadjuvant chemotherapy in cervical cancer[J].Gynecol Oncol,2007,107 (Suppl 1):20-22.

共引文献23

同被引文献42

  • 1PARK JY,NGAN HY,PARK W,etal.Asian Society of Gyne- cologic Oncology International Workshop 2014[J].J Gynecol Oncol,2014,26(1):68-74.
  • 2TORRE LA,BRAY F,SIEGEL RL,et al.Global cancer statis- tics,2012[J].CA Cancer J Clin,2015,65(2):87-108.
  • 3FERLAY J,SOERJOMATARAM I,DIKSHIT R,et al.Cancer incidence and mortality worldwide:sources,methods and major patterns in GLOBOCAN 2012[J].Int J Cancer,2015,136(5):359-386.
  • 4GARG G,SHAH JP,TOY EP,et al.Stage II Al versus stage II A2 cervical cancer:does the new staging criteria predict survival[J].Int J Gynecol Cancer,2011,21(4):711-716.
  • 5WANG J,WANG T,YANG YY,et al.Patient age,tumor ap- pearance and tumor size are risk factors for early recurrence of cervical cancer[J].Mol Clin Oncol,2015,3(2):363-366.
  • 6SEHOUU J,RUNNEBAUM IB,FOTOPOULOU C,et al.A randomized phase HI adjuvant study in high-risk cervical can- cer:simultaneous radiochemotherapy with cisplatin(S-RC)ver- sus systemic paclitaxel and carboplatin followed by percutaneous radiation(PC-R):a NOGGO-AGO Intergroup Study[J].Ann Oncol,2012,23(9):2259-2264.
  • 7GRUEN A,MUSIK T,KHLER C,et al.Adjuvant Chemoradia- tion after Laparoscopically Assisted Radical Vaginal Hysterecto- my(LARVH)in Patients with Cervical Cancer Oncologic Out- come and Morbidity[J].Strahlenther Onkol,2011,187(6):344-349.
  • 8SERT MB,ABELER V.Robot-assisted laparoscopic radical hys- terectomy:comparison with total laparoscopic hysterectomy and abdominal radical hysterectomy one surgeon' s experience at the Norwegian Radium Hospital[J].Gynecol Oncol,2011,121(3):600-604.
  • 9HONG JH,CHOI JS,LEE JH,et al.Comparison of survival and adverse events between women with stage ⅠB1 and stage ⅠB2 cervical cancer treated by laparoscopic radical vaginal hys- terectomy[J].Ann Surg Oncol,2012,19(6):605-611.
  • 10RAMIREZ PT,PAREJA R,RENDCN GJ,et al.Management of low-risk early-stage cervical cancer:Should conization,sim- ple trachelectomy,or simple hysterectomy replace radical surgery as the new standard of care[J].Gynecol Oncol,2014,132(1):254-259.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部